By his estimate, that means AI has been around at Sanofi for about a third of the "discovery" process for some drugs. That ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Pharmaceutical company Novo Nordisk has announced it ... Zilbermint highlights Lantus (insulin glargine) as a good option. Although Levermir and Lantus have different chemical structures, both ...

Generic drugmaker Viatris has become the first company to secure FDA approval ... reference product – namely Sanofi's once-daily insulin Lantus. Semglee has been approved for over a year as ...

The biosimilars – which will be interchangeable with Sanofi's Lantus (insulin glargine), Novo ... Last year, Viatris became the first company to secure FDA approval for a biosimilar product ...

Telehealth platform GoodRx has become the latest company to offer people with ... patients a coupon for to a 30-day supply of Lantus, an insulin glargine injection and Sanofi's most widely ...

It took another year for the FDA to grant interchangeability status to Rezvoglar, meaning it can be substituted at the pharmacy for Lantus, the brand name insulin glargine, without needing a separate ...

Coverage can vary among plans sponsored by the same insurance company ... as Lantus or Novolog, a pop-up box notes, “Your drug has a generic” that may cost less. In the case of insulin ...

that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions of its drug — Semglee cost $269 and a generic ...

The pharmaceutical company, which makes drugs like Lantus insulin jabs and Plavix blood thinners, spends about three billion euros, or $3.1 billion, on discovery within that timeframe, Hudson said.